[Neurotoxicity of some antineoplastic agents].
D000970:Antineoplastic Agents / Q000009:adverse effects*; D002648:Child; D002675:Child, Preschool; D004317:Doxorubicin / Q000009:adverse effects / Q000627:therapeutic use; D005158:Facial Paralysis / Q000139:chemically induced; D006801:Humans; D007223:Infant; D007938:Leukemia / Q000188:drug therapy; D008223:Lymphoma / Q000188:drug therapy; D008727:Methotrexate / Q000009:adverse effects / Q000627:therapeutic use; D009046:Motor Neurons / Q000187:drug effects; D009157:Myasthenia Gravis / Q000139:chemically induced; D009369:Neoplasms / Q000188:drug therapy*; D009420:Nervous System / Q000187:drug effects*; D009422:Nervous System Diseases / Q000139:chemically induced*; D010292:Paresthesia / Q000139:chemically induced; D012640:Seizures / Q000139:chemically induced; D014747:Vinblastine / Q000009:adverse effects / Q000627:therapeutic use; D014750:Vincristine / Q000009:adverse effects / Q000627:therapeutic use
D000970:Antineoplastic Agents; D014750:Vincristine; D014747:Vinblastine; D004317:Doxorubicin; D008727:Methotrexate
Neurotossicita' di alcuni agenti antitumorali